DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR Tick-borne infections in patients under anti-CD therapy...
       0 replies
   DIR Medicare Part D formulary coverage of DMTs for MS
       1 replies
   DIR (Abst.) Outcome predictors in PML associated w/MS treatments...
       0 replies
   DIR Stem cell medical tourism leads to meningitis in MS patient
       1 replies
   DIR FDA fails to approve tolebrutinib for MS
       0 replies
   DIR Rituxan (rituximab)
       30 replies
   DIR FDA side effects update: New liver injury warnings for MS drug...
       0 replies
   DIR Chronic progressive MS market to witness accelerated expansion...
       0 replies
   DIR (Abst.) Moderate-high efficacy DMTs reduce relapse risk in lat...
       0 replies
   DIR Ibudilast receives fast track designation--studied for SPMS an...
       9 replies
       *****************************************************
       Page 1 of 29
   DIR Next Page